Preclinical Studies on Emergo Therapeutics Lead Molecule for Acute Inflammatory Conditions

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Organization
Emergo Therapeutics, Inc.
Award Date
Award Amount
75,000
Program Name
Company Inception Loan
Program Category
Business Financing
Principal Investigator
Robin Hyde-DeRuyscher
Fiscal Year
2017
Region
Research Triangle
Project Description: Emergo is developing pharmaceutical products for treating acute inflammatory conditions. CIL funds will be used to fund preclinical efficacy studies in animal models.
scroll back to top of page